US President Donald Trump announced that nine major pharmaceutical companies have agreed to slash prices on many of their prescription medicines, particularly for low-income patients and uninsured Americans.  The agreements are part of the Trump administration’s “most-favored-nation” (MFN) plan, which aims to “align US prices more closely with those paid in other wealthy nations,” according […]